Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fleck

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Neuro-Oncology|April 5, 2020
GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant gliomaSascha Marx, Fabian Wilken, Isabel Wagner, et al.
Neurosurgical Review|July 12, 2020
Quality of life and olfactory function after suprasellar craniopharyngioma surgery-a single-center experience comparing transcranial and endoscopic endonasal approachesSascha Marx, Ioanna Tsavdaridou, Sebastian Paul, et al.
Physics in Medicine and Biology|July 7, 2025
Single-pulse Gy-scale irradiation of biological cells at 10<sup>13</sup> Gy s<sup>-1</sup>average dose-rates from a laser-wakefield acceleratorC A McAnespie, P Chaudhary, M J V Streeter, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Neuro-Oncology|April 5, 2020
GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant gliomaSascha Marx, Fabian Wilken, Isabel Wagner, et al.
Neurosurgical Review|July 12, 2020
Quality of life and olfactory function after suprasellar craniopharyngioma surgery-a single-center experience comparing transcranial and endoscopic endonasal approachesSascha Marx, Ioanna Tsavdaridou, Sebastian Paul, et al.
Physics in Medicine and Biology|July 7, 2025
Single-pulse Gy-scale irradiation of biological cells at 10<sup>13</sup> Gy s<sup>-1</sup>average dose-rates from a laser-wakefield acceleratorC A McAnespie, P Chaudhary, M J V Streeter, et al.
Pageof 3